Company attributes
Industry
Location
B2X
Founder
Pitchbook URL
Number of Employees (Ranges)
1 – 10
Email Address
pr@oerthbio.com0
careers@oerthbio.com0
bd@oerthbio.com0
Full Address
112 South Duke Street, Suite 1 Durham, North Carolina 27701 United States0
Total Funding Amount (USD)
55,000,000
Latest Funding Round Date
February 2020
CTO
Latest Funding Type
COO
Country
Other attributes
Company Operating Status
Active
Oerth Bio is a developer of targeted protein degraders for agricultural applications. The company leverages Arvinas' novel PROTAC protein degrader technology to develop human therapeutics for patients with cardiovascular, oncological, and gynecological diseases.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
